Clindamycin Hydrochloride
Product Images NDC 70934-144

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 70934-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 144 80 Master Bottle Label Approval Rev B 10 19

70934 144 80 Master Bottle Label Approval Rev B 10 19
Label for Clindamycin Hydrochloride Capsules USP 150 mg by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The package contains 80 capsules with storage instructions and dosage information. The label includes the NDC 70934-144-80 and manufacturing details.*
FDA Label Image

Clindamycin-hcl-molecular-structure (Clindamycin Hydrochloride Capsules Usp 1)

Clindamycin-hcl-molecular-structure (Clindamycin Hydrochloride Capsules Usp 1)
Chemical structure of Clindamycin Hydrochloride, showing the molecular formula C18H33ClN2O5S·HCl and molecular weight 461.45. The structure includes a sugar moiety linked to a chlorine-containing amino acid derivative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.